Total Payments
$15,049
2024 Payments
$1,669
Companies
41
Transactions
523
Medicare Patients
2,037
Medicare Billing
$173,379
Payment Breakdown by Category
Food & Beverage$10,132 (67.3%)
Research$3,300 (21.9%)
Travel$1,514 (10.1%)
Consulting$50.00 (0.3%)
Education$27.75 (0.2%)
Other$25.00 (0.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $10,132 | 511 | 67.3% |
| Unspecified | $3,300 | 1 | 21.9% |
| Travel and Lodging | $1,514 | 6 | 10.1% |
| Consulting Fee | $50.00 | 1 | 0.3% |
| Education | $27.75 | 3 | 0.2% |
| Honoraria | $25.00 | 1 | 0.2% |
Payments by Type
General
$11,749
522 transactions
Research
$3,300
1 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Lupin Inc. | $3,300 | 1 | $0 (2018) |
| AstraZeneca Pharmaceuticals LP | $3,049 | 85 | $0 (2024) |
| GlaxoSmithKline, LLC. | $1,697 | 89 | $0 (2024) |
| GENZYME CORPORATION | $788.56 | 23 | $0 (2024) |
| CSL Behring | $626.98 | 36 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $577.69 | 32 | $0 (2024) |
| Merck Sharp & Dohme LLC | $560.88 | 8 | $0 (2023) |
| PFIZER INC. | $436.78 | 23 | $0 (2024) |
| Genentech USA, Inc. | $418.15 | 22 | $0 (2024) |
| ABBVIE INC. | $341.24 | 17 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,669 | 75 | GENZYME CORPORATION ($266.31) |
| 2023 | $2,379 | 54 | AstraZeneca Pharmaceuticals LP ($1,622) |
| 2022 | $823.30 | 41 | ABBVIE INC. ($239.79) |
| 2021 | $1,044 | 57 | GlaxoSmithKline, LLC. ($236.47) |
| 2020 | $1,080 | 67 | GlaxoSmithKline, LLC. ($255.04) |
| 2019 | $1,789 | 99 | AstraZeneca Pharmaceuticals LP ($470.61) |
| 2018 | $4,521 | 52 | Lupin Inc. ($3,300) |
| 2017 | $1,744 | 78 | GlaxoSmithKline, LLC. ($362.82) |
All Payment Transactions
523 individual payment records from CMS Open Payments — Page 1 of 21
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $18.40 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 12/19/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $18.01 | General |
| Category: RESPIRATORY | ||||||
| 12/19/2024 | CSL Behring | Haegarda (Biological) | Food and Beverage | In-kind items and services | $16.27 | General |
| Category: Immunology | ||||||
| 12/12/2024 | Amgen Inc. | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $16.85 | General |
| Category: Inflammation | ||||||
| 12/09/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $16.93 | General |
| Category: Respiratory | ||||||
| 11/25/2024 | PFIZER INC. | OCTAGAM IMMUNE GLOBULIN (HUMAN) (Drug), PANZYGA, CUTAQUIG | Food and Beverage | In-kind items and services | $16.18 | General |
| Category: IMMUNOLOGY | ||||||
| 11/22/2024 | Amgen Inc. | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $17.96 | General |
| Category: Inflammation | ||||||
| 11/20/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $17.10 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/20/2024 | Genentech USA, Inc. | Xolair (Biological) | Food and Beverage | In-kind items and services | $13.62 | General |
| Category: Immunology | ||||||
| 11/19/2024 | Lilly USA, LLC | EBGLYSS (Drug) | Food and Beverage | In-kind items and services | $14.95 | General |
| Category: Immunology | ||||||
| 11/15/2024 | CSL Behring | Haegarda (Biological) | Food and Beverage | In-kind items and services | $18.13 | General |
| Category: Immunology | ||||||
| 11/14/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $14.79 | General |
| Category: Respiratory | ||||||
| 11/13/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $16.52 | General |
| Category: RESPIRATORY | ||||||
| 11/07/2024 | Genentech USA, Inc. | Xolair (Biological) | Food and Beverage | In-kind items and services | $14.66 | General |
| Category: Immunology | ||||||
| 11/06/2024 | CSL Behring | Haegarda (Biological) | Food and Beverage | In-kind items and services | $18.98 | General |
| Category: Immunology | ||||||
| 10/26/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $110.32 | General |
| Category: Immunology | ||||||
| 10/26/2024 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $65.40 | General |
| 10/25/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $123.92 | General |
| Category: Immunology | ||||||
| 10/25/2024 | Blueprint Medicines Corporation | AYVAKIT (Drug) | Food and Beverage | In-kind items and services | $17.00 | General |
| Category: Oncology / Rare Diseases | ||||||
| 10/24/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $16.04 | General |
| Category: Dermatology | ||||||
| 10/17/2024 | Amgen Inc. | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $16.03 | General |
| Category: Inflammation | ||||||
| 10/16/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $17.77 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 10/10/2024 | Takeda Pharmaceuticals U.S.A., Inc. | CUVITRU (Biological) | Food and Beverage | In-kind items and services | $21.93 | General |
| Category: IMMUNOLOGY | ||||||
| 09/26/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $20.32 | General |
| Category: Immunology | ||||||
| 09/25/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $13.09 | General |
| Category: RESPIRATORY | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| A RANDOMIZED, DOUBLE-BLIND, DOUBLE-DUMMY, PLACEBO-CONTROLLED, PARALLEL-GROUP, MULTICENTER CLINICAL STUDY TO ASSESS THE EFFICACY AND SAFETY OF TWICE DAILY ADMINISTRATION OF FLUTICASONE PROPIONATE 100 MCG AND SALMETEROL XINAFOATE 50 MCG DRY POWDER INHALER COMPARED TO ADMINISTRATION WITH ADVAIR DISKUS 10050 MCG TWICE DAILY AND PLACEBO IN PATIENTS 12 YEARS OF AGE AND OLDER WITH REVERSIBLE PERSISTENT ASTHMA INCLUDING A 3-WEEK OPEN-LABEL EXTENSION TO ASSESS INHALER ROBUSTNESS | Lupin Inc. | $3,300 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 491 | 2,421 | $122,282 | $43,385 |
| 2022 | 12 | 474 | 2,427 | $94,971 | $40,526 |
| 2021 | 16 | 527 | 2,775 | $106,064 | $49,262 |
| 2020 | 13 | 545 | 2,534 | $97,560 | $40,206 |
Total Patients
2,037
Total Services
10,157
Medicare Billing
$173,379
Procedure Codes
54
All Medicare Procedures & Services
54 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 89 | 125 | $27,416 | $11,969 | 43.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 42 | 42 | $13,207 | $5,503 | 41.7% |
| 95165 | Professional service for preparation and provision of 1 or more antigens | Office | 2023 | 41 | 490 | $13,990 | $5,129 | 36.7% |
| 95018 | Test for allergy using combination of methods with drug or biological | Office | 2023 | 17 | 235 | $9,923 | $4,129 | 41.6% |
| 95117 | Professional service for multiple injections of allergen | Office | 2023 | 34 | 407 | $15,524 | $3,748 | 24.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 47 | 48 | $7,407 | $3,343 | 45.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 13 | 20 | $6,114 | $3,001 | 49.1% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 12 | 230 | $11,850 | $2,632 | 22.2% |
| 95004 | Test for allergy using allergenic extract | Office | 2023 | 21 | 505 | $7,260 | $1,664 | 22.9% |
| 95115 | Professional service for single injection of allergen | Office | 2023 | 13 | 112 | $3,265 | $857.28 | 26.3% |
| 94010 | Test to measure expiratory airflow and volume | Office | 2023 | 28 | 32 | $2,870 | $680.05 | 23.7% |
| 95012 | Test to measure the level of nitric oxide gas | Office | 2023 | 25 | 28 | $1,084 | $417.25 | 38.5% |
| 96160 | Administration and interpretation of patient-focused health risk assessment | Office | 2023 | 109 | 147 | $2,372 | $313.09 | 13.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 71 | 99 | $18,810 | $10,291 | 54.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 59 | 59 | $17,110 | $7,995 | 46.7% |
| 95165 | Professional service for preparation and provision of 1 or more antigens | Office | 2022 | 38 | 495 | $13,365 | $5,745 | 43.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 64 | 67 | $8,844 | $4,581 | 51.8% |
| 95117 | Professional service for multiple injections of allergen | Office | 2022 | 31 | 385 | $12,320 | $3,552 | 28.8% |
| 95004 | Test for allergy using allergenic extract | Office | 2022 | 31 | 883 | $11,479 | $3,034 | 26.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 11 | 15 | $3,945 | $2,301 | 58.3% |
| 95115 | Professional service for single injection of allergen | Office | 2022 | 14 | 220 | $5,500 | $1,651 | 30.0% |
| 94010 | Test to measure expiratory airflow and volume | Office | 2022 | 18 | 21 | $1,323 | $502.73 | 38.0% |
| 96160 | Administration and interpretation of patient-focused health risk assessment | Office | 2022 | 108 | 152 | $1,254 | $356.53 | 28.4% |
| 95012 | Test to measure the level of nitric oxide gas | Office | 2022 | 18 | 20 | $680.00 | $346.83 | 51.0% |
| 94664 | Evaluation of use of breathing device | Office | 2022 | 11 | 11 | $341.00 | $170.50 | 50.0% |
About Dr. Gary Gross, MD
Dr. Gary Gross, MD is a Allergy & Immunology healthcare provider based in Ocean, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/08/2005. The National Provider Identifier (NPI) number assigned to this provider is 1336143247.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Gary Gross, MD has received a total of $15,049 in payments from pharmaceutical and medical device companies, with $1,669 received in 2024. These payments were reported across 523 transactions from 41 companies. The most common payment nature is "Food and Beverage" ($10,132).
As a Medicare-enrolled provider, Gross has provided services to 2,037 Medicare beneficiaries, totaling 10,157 services with total Medicare billing of $173,379. Data is available for 4 years (2020–2023), covering 54 distinct procedure/service records.
Ad
Practice Information
- Specialty Allergy & Immunology
- Other Specialties Allergy & Immunology
- Location Ocean, NJ
- Active Since 06/08/2005
- Last Updated 10/30/2023
- Taxonomy Code 207K00000X
- Entity Type Individual
- NPI Number 1336143247
Products in Payments
- ADVAIR (Drug) $3,300
- BREZTRI (Drug) $1,566
- DUPIXENT (Biological) $785.26
- NUCALA (Biological) $619.70
- FASENRA (Drug) $570.59
- TRELEGY ELLIPTA (Drug) $565.69
- MK-7264 (Drug) $530.47
- Xolair (Biological) $418.15
- Hizentra (Biological) $364.75
- RINVOQ (Biological) $341.24
- XOLAIR (Biological) $325.80
- CUVITRU (Biological) $319.66
- TEZSPIRE (Biological) $264.83
- Haegarda (Biological) $262.23
- FASENRA (Biological) $251.29
- EUCRISA (Drug) $232.69
- SYMBICORT (Drug) $221.49
- BREO (Drug) $221.45
- RUCONEST (Biological) $195.66
- DUPIXENT (Drug) $190.68
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.